Editas Medicine (EDIT) Share-based Compensation (QoQ) (2015 - 2025)
Editas Medicine (EDIT) Share-based Compensation (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 104.81% |
| Dec 31, 2024 | -195.87% |
| Sep 30, 2024 | 344.49% |
| Jun 30, 2024 | -189.53% |
| Mar 31, 2024 | 164.82% |
| Dec 31, 2023 | -347.33% |
| Sep 30, 2023 | -9.28% |
| Jun 30, 2023 | 15.71% |
| Mar 31, 2023 | 195.73% |
| Dec 31, 2022 | -180.05% |
| Sep 30, 2022 | -11.14% |
| Jun 30, 2022 | -42.10% |
| Mar 31, 2022 | 195.21% |
| Dec 31, 2021 | -219.92% |
| Sep 30, 2021 | 1,803.42% |
| Jun 30, 2021 | -95.69% |
| Mar 31, 2021 | 115.12% |
| Dec 31, 2020 | -2.96% |
| Sep 30, 2020 | 1,570.29% |
| Jun 30, 2020 | -94.37% |